Nautilus Biotechnology (NAUT) Share-based Compensation (2020 - 2026)

Nautilus Biotechnology (NAUT) has 7 years of Share-based Compensation data on file, last reported at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation fell 37.18% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $6.0 million (down 48.63% YoY), and the FY2025 full-year result was $6.8 million, down 46.11% from the prior year.
• Share-based Compensation retreated to $1.4 million in Q1 2026, from $1.5 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $7.5 million in Q3 2022 to a low of -$2.1 million in Q2 2022.
• A 5-year average of $2.3 million and a median of $2.2 million in 2025 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation sank 215.93% in 2022 and soared 325.73% in 2023, its largest moves.
• Tracing NAUT's Share-based Compensation over 5 years: stood at $2.8 million in 2022, then tumbled by 150.86% to -$1.4 million in 2023, then soared by 316.79% to $3.1 million in 2024, then tumbled by 52.91% to $1.5 million in 2025, then fell by 7.41% to $1.4 million in 2026.
• Business Quant data shows NAUT's Share-based Compensation at $1.4 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.